- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Estrogen Receptor-Positive Breast Carcinoma in Denmark
Total 31 results
-
Aarhus University HospitalOdense University Hospital; Rigshospitalet, Denmark; University of Copenhagen; Herning... and other collaboratorsRecruitingBreast Cancer Female | Estrogen Receptor Positive TumorDenmark
-
Aarhus University HospitalDanish Cancer SocietyRecruitingMetastatic Breast Cancer | Adiposity | Estrogen-receptor-positive Breast CancerDenmark
-
Hoffmann-La RocheActive, not recruitingEstrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast CancerUnited States, Italy, Korea, Republic of, Canada, Germany, United Kingdom, Australia, Belgium, Brazil, China, Denmark, France, Hong Kong, Portugal, Spain, Taiwan, Turkey, Japan, Argentina, Mexico, Israel, Poland, Russian Federation, A... and more
-
Dorte NielsenTerminated
-
Danish Breast Cancer Cooperative GroupDanish Cancer SocietyActive, not recruitingBreast Cancer | Carcinoma in Situ of the BreastDenmark
-
University of AarhusDanish Cancer SocietyCompletedBreast Cancer | Carcinoma in Situ of the BreastDenmark
-
Danish Breast Cancer Cooperative GroupDanish Cancer Society; Danish Center for Interventional Research in Radiation...Active, not recruitingBreast CarcinomaDenmark
-
Zealand University HospitalCopenhagen University Hospital, DenmarkCompletedBreast Cancer | Ductal Carcinoma in SituDenmark
-
Rigshospitalet, DenmarkCompleted
-
Rigshospitalet, DenmarkRecruiting
-
Odense University HospitalAarhus University Hospital; University of Copenhagen; Aalborg University HospitalRecruitingHER2-positive Breast Cancer | CardiotoxicityDenmark
-
Rigshospitalet, DenmarkEnrolling by invitationSarcoma | Lymphoma | Breast Cancer | Neuroendocrine Tumors | Neuroendocrine Carcinoma | Neuroendocrine Carcinoma MetastaticDenmark
-
Rigshospitalet, DenmarkUnknownBreast Cancer | Ovarian Cancer | Neuroendocrine CarcinomaDenmark
-
AstraZenecaDaiichi SankyoActive, not recruitingBreast Cancer; HER2-positive; MetastaticUnited States, Belgium, Canada, Denmark, Italy, Spain, Hungary, Taiwan, Turkey, France, Germany, Korea, Republic of, Brazil, India, Japan, Peru, Philippines, United Kingdom, China, South Africa, Israel, Russian Federation, Argentina, ... and more
-
Seagen Inc.RecruitingHER2-positive Breast CancerUnited States, Australia, Austria, Belgium, Canada, China, Denmark, France, Germany, Israel, Italy, Japan, Korea, Republic of, Netherlands, Singapore, Spain, Sweden, Switzerland, Taiwan, United Kingdom
-
Herlev HospitalCompletedBreast Cancer | Colorectal Cancer | Ovarian Cancer | Non Small Cell Lung Cancer | Metastatic Cancer | Squamous Cell Carcinoma of the Head and Neck | Urothelial Carcinoma | Malignant MelanomaDenmark
-
GenmabAbbVieTerminatedEsophageal Cancer | Prostate Cancer | Bladder Cancer | Non-small Cell Lung Cancer (NSCLC) | Uterine Cancer | Triple Negative Breast Cancer (TNBC) | Squamous Cell Carcinoma of Head and Neck (SCCHN) | Locally Advanced or Metastatic Solid Tumor(s)Spain, Israel, United States, Denmark
-
Eli Lilly and CompanyTerminatedRenal Cell Carcinoma | Solid Tumor | Non Small Cell Lung Cancer | Triple Negative Breast CancerBelgium, Spain, United States, France, Italy, Denmark
-
Seagen Inc.CompletedHER2 Positive Breast CancerUnited States, Spain, Belgium, Germany, Israel, France, United Kingdom, Austria, Denmark, Italy, Australia, Canada, Czechia, Portugal, Switzerland
-
Daiichi Sankyo, Inc.AstraZeneca; NSABP Foundation Inc; German Breast Group; Spanish Breast Cancer Research...Active, not recruitingHER2-Positive Primary Breast Cancer | Residual Invasive Breast CancerUnited States, Spain, France, Germany, Korea, Republic of, United Kingdom, Denmark, Israel, Belgium, Taiwan, Chile, Italy, Japan, Peru, Portugal, China, Turkey, Canada, Ireland, Australia, Greece, Czechia, Singapore, Poland, Romania, Arge... and more
-
MacroGenicsCompletedHER-2 Positive Breast Cancer | Metastatic NeoplasmUnited States, Spain, Italy, Canada, Israel, Belgium, Germany, Czechia, Austria, Korea, Republic of, Denmark, United Kingdom, Portugal, France, Poland, Netherlands, Finland, Puerto Rico
-
Hoffmann-La RocheTerminatedTriple Negative Breast Cancer | Advanced Ovarian CancerUnited Kingdom, United States, Australia, Denmark, Canada
-
University of AarhusDanish Cancer Society; Arvid-Nilsson FoundationUnknown
-
University of Southern DenmarkOdense University HospitalCompletedBreast Cancer | Gastric Cancer | Rectal Cancer | Bile Duct Cancer | Colon Cancer | Pancreas Cancer | Oesophageal Cancer | Adverse Drug EventDenmark
-
Eli Lilly and CompanyCompletedSoft Tissue Sarcoma | Breast Cancer | Solid Tumor | Cholangiocarcinoma | Colon CancerUnited States, France, Spain, Denmark
-
Bristol-Myers SquibbCompletedChronic Myeloid Leukemia | Leukemia, Lymphoblastic, Acute, Philadelphia-positiveNetherlands, United States, Italy, Argentina, Austria, Brazil, Canada, Germany, Peru, United Kingdom, France, Korea, Republic of, Sweden, Finland, Australia, Israel, Belgium, Denmark, Norway, Switzerland
-
AstraZenecaActive, not recruitingCervical Cancer | Ovarian Cancer | Pharmacokinetics | Endometrial Cancer | Pharmacodynamics | Safety and Tolerability | Advanced Solid Malignancy | Tumour Response | Advanced or Metastatic Breast Cancer | PIK3CA | AKT1 | PTEN | ER Positive | HER2 PositiveUnited States, Italy, Canada, France, Japan, United Kingdom, Spain, Netherlands, Denmark, Singapore
-
Bristol-Myers SquibbCompletedChronic Myeloid Leukemia | Blast CrisisNetherlands, United States, Italy, Austria, Canada, France, Germany, Singapore, Taiwan, United Kingdom, Australia, Korea, Republic of, Philippines, Sweden, Finland, Israel, Belgium, Denmark, Norway, Switzerland
-
Incyte Biosciences International SàrlRecruitingLymphoma | Acute Myeloid Leukemia | Leukemia | Acute Lymphoblastic Leukemia | Acute Lymphocytic Leukemia | Solid Tumors | Chronic Phase Chronic Myeloid Leukemia | Accelerated Phase Chronic Myeloid Leukemia | Blast Phase Chronic Myeloid LeukemiaSpain, Italy, France, Germany, United Kingdom, Belgium, Sweden, Denmark, Netherlands
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedPreviously Treated Myelodysplastic Syndrome | Recurrent Adult Acute Myeloid Leukemia | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent Adult Diffuse Small Cleaved Cell Lymphoma | Recurrent Adult Lymphoblastic... and other conditionsUnited States, Germany, Denmark
-
Incyte CorporationCompletedBreast Cancer | Multiple Myeloma | Gastric Cancer | Lung Cancer | Solid Tumor | Cholangiocarcinoma | Endometrial Cancer | Urothelial Cancer | Myeloproliferative Neoplasms | UC | MPNUnited States, Denmark